Filing Flows › FMC (FMC) › Q3 2026 › vs Q3 2025
FMC (FMC) Q3 2026 vs Q3 2025 (year over year)
FMC's revenue fell $436M (-80%) from $542M in Q3 2025 to $106M in Q3 2026.
FMC, Q3 2026: revenue $106M (-80% year over year), net loss $2.1B, operating cash flow $6.6M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $106M | $542M | −$436M | -80% |
| Net loss | $2.1B | $569M | $1.5B | +263% |
| Costs & expenses | $2.2B | $1.1B | $1.1B | +95% |
| Operating costs | $1.2B | $938M | $280M | +30% |
| Interest & other, net | $112M | $90.1M | $22.4M | +25% |
| Income tax | $841M | $82.2M | $758M | +923% |
| Research & development | $57.7M | $63.3M | −$5.6M | -9% |
| SG&A | $172M | $167M | $4.9M | +3% |
| Other operating costs | $481M | $294M | $186M | +63% |
| Operating cash sources | $2.1B | $384M | $1.7B | +439% |
| Depreciation & amortization | $40.9M | $43.4M | −$2.5M | -6% |
| Share-based compensation | $7.3M | $6.8M | $500K | +7% |
| Working capital & other | $2.0B | $334M | $1.7B | +506% |
| Net loss absorbed | $2.1B | $569M | $1.5B | +263% |
| Operating cash flow | $6.6M | −$184M | $191M | — |
| Capital expenditures | $7.8M | $23.7M | −$15.9M | -67% |
| Negative free cash flow (OCF − capex) | $1.2M | $208M | −$207M | -99% |
Questions
How much did FMC's revenue grow year over year in Q3 2026?
FMC's revenue fell $436M (-80%) from $542M in Q3 2025 to $106M in Q3 2026.